Literature DB >> 17184940

Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.

Tamaki Miyazaki1, Sumie Yoshioka, Yukio Aso, Toru Kawanishi.   

Abstract

To examine the relative contributions of molecular mobility and thermodynamic factor, the relationship between glass transition temperature (T(g)) and the crystallization rate was examined using amorphous dihydropyridines (nifedipine (NFD), m-nifedipine (m-NFD), nitrendipine (NTR) and nilvadipine (NLV)) with differing T(g) values. The time required for 10% crystallization, t(90), was calculated from the time course of decreases in the heat capacity change at T(g). The t(90) of NLV and NTR decreased with decreases in T(g) associated with water sorption. The t(90) versus T(g)/T plots almost overlapped for samples of differing water contents, indicating that the crystallization rate is determined by molecular mobility as indicated by T(g). In contrast, differences in the crystallization rate between these four drugs cannot be explained only by molecular mobility, since the t(90) values at a given T(g)/T were in the order: NLV>NTR>NFD approximately m-NFD. A lower rate was obtained for amorphous drugs with lower structural symmetry and more bulky functional groups, suggesting that these factors are also important. Furthermore, the crystallization rate of NTR in solid dispersions with poly(vinylpyrrolidone) (PVP) and hydroxypropyl methylcellulose (HPMC) decreased to a greater extent than expected from the increased T(g). This also suggests that factors other than molecular mobility affect the crystallization rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184940     DOI: 10.1016/j.ijpharm.2006.11.052

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  A practical method to predict physical stability of amorphous solid dispersions.

Authors:  Stéphanie Greco; Jean-René Authelin; Caroline Leveder; Audrey Segalini
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation.

Authors:  Xin Feng; Xingyou Ye; Jun-Bom Park; Wenli Lu; Joe Morott; Brad Beissner; Zhuoyang John Lian; Elanor Pinto; Vivian Bi; Stu Porter; Tom Durig; Soumyajit Majumdar; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-07-21       Impact factor: 3.225

3.  Nifedipine-pyrazine (2/1).

Authors:  Nate Schultheiss; Melanie Roe; Jared P Smit
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

4.  Development and evaluation of solid dispersion of spironolactone using fusion method.

Authors:  Mohammad Fazil; Shahid Husain Ansari; Javed Ali
Journal:  Int J Pharm Investig       Date:  2016 Jan-Mar

5.  In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.

Authors:  Abdulmalik Alqurshi; K L Andrew Chan; Paul G Royall
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

Review 6.  Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.

Authors:  Kohsaku Kawakami
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

7.  Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms.

Authors:  Jose R Cerda; Talaya Arifi; Sejad Ayyoubi; Peter Knief; Maria Paloma Ballesteros; William Keeble; Eugen Barbu; Anne Marie Healy; Aikaterini Lalatsa; Dolores R Serrano
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.